Shilpa Medicare Raichur facility gets Russian GMP certificate
Hyderabad: Shilpa Medicare Limited has recently announced that the Company's API facility (unit-1) located at Raichur, Karnataka has received GMP certificate from MOH-Russia.
"The facility was audited by the agency on 17 February 2022, 18 February 2022 and 21 February 2022," the company said in a recent BSE filing.
The facility involves in manufacturing, testing, packing, storage of chemically synthesized nonsterile drug substances for human use.
Read also: Shilpa Medicare gets 4 USFDA observations for Hyderabad division
Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India.
The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.
Read also: Shilpa Medicare clears USFDA review for Dabaspet facility
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.